Chemical Structure (Livmarli 01)
Livmarli Solution
Product Images NDC 79378-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Livmarli (NDC 79378-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mirum Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Livmarli 02)
This product appears to include a child-resistant cap and a bottle adapter designed to fit onto a bottle. No further information is available to provide a more detailed description or context.*
Figure B (Livmarli 03)
Figure C (Livmarli 04)
Figure D (Livmarli 05)
Figure E (Livmarli 06)
Figure F (Livmarli 07)
Figure G (Livmarli 08)
This is information about a medical device, likely a syringe. It includes markings for the dose and the tip of the device, as well as information about the barrel, flange, and plunger. There is an "E-S" and a "5" marked on the device.*
Figure H (Livmarli 09)
Figure I (Livmarli 10)
Figure J (Livmarli 11)
Figure K (Livmarli 12)
Figure L (Livmarli 13)
Figure M (Livmarli 14)
Figure N (Livmarli 15)
Figure O (Livmarli 16)
Figure P (Livmarli 17)
Figure Q (Livmarli 18)
Figure R (Livmarli 19)
Figure S (Livmarli 20)
Figure T (Livmarli 21)
Figure U (Livmarli 22)
Figure V (Livmarli 23)
Figure W (Livmarli 24)
Figure X (Livmarli 25)
Principal Display Panel (30 mL Bottle Label)
Livmarli 27
Livmarli 28
Livmarli 29
This is a description of a medication with the National Drug Code (NDC) 79378-110-01. The medication is called N Llvmarllm and is recommended to be stored unopened at 20°C - 25°C (68°F - 77°F). After opening, it should be stored at the same temperature range and should be disposed of any remaining medication after 45 days. The medication should be kept out of the reach of children. The dosage information is provided in the prescribing information. The medicine has been manufactured by Mirum Pharmaceuticals, Inc. in Foster City, California, and is made in Canada. The LOT is mentioned but the XXXXX is not identifiable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
